David L. Rimm

1980–2025 年に発表

294
論文数
61,344
被引用数
132
h 指数
283
i10 指数

被引用数

David L. Rimm の年別被引用数1976 年: 被引用 1 件1978 年: 被引用 1 件1981 年: 被引用 2 件1982 年: 被引用 10 件1983 年: 被引用 17 件1984 年: 被引用 5 件1985 年: 被引用 19 件1986 年: 被引用 12 件1987 年: 被引用 11 件1988 年: 被引用 2 件1989 年: 被引用 2 件1990 年: 被引用 6 件1991 年: 被引用 2 件1993 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 22 件1996 年: 被引用 63 件1997 年: 被引用 71 件1998 年: 被引用 100 件1999 年: 被引用 110 件2000 年: 被引用 109 件2001 年: 被引用 125 件2002 年: 被引用 148 件2003 年: 被引用 172 件2004 年: 被引用 189 件2005 年: 被引用 215 件2006 年: 被引用 247 件2007 年: 被引用 286 件2008 年: 被引用 307 件2009 年: 被引用 322 件2010 年: 被引用 361 件2011 年: 被引用 364 件2012 年: 被引用 351 件2013 年: 被引用 338 件2014 年: 被引用 329 件2015 年: 被引用 404 件2016 年: 被引用 537 件2017 年: 被引用 625 件2018 年: 被引用 602 件2019 年: 被引用 2,036 件2020 年: 被引用 2,661 件2021 年: 被引用 3,082 件2022 年: 被引用 2,591 件2023 年: 被引用 2,157 件2024 年: 被引用 2,953 件2025 年: 被引用 1,587 件2026 年: 被引用 83 件1977 年は被引用が無いため表示していません1979〜1980 年は被引用が無いため表示していません1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,438 件、この内訳の 25.7%中国: 引用元論文 4,859 件、この内訳の 16.8%イギリス: 引用元論文 1,553 件、この内訳の 5.4%ドイツ: 引用元論文 1,308 件、この内訳の 4.5%イタリア: 引用元論文 1,275 件、この内訳の 4.4%フランス: 引用元論文 943 件、この内訳の 3.3%日本: 引用元論文 922 件、この内訳の 3.2%カナダ: 引用元論文 907 件、この内訳の 3.1%オーストラリア: 引用元論文 795 件、この内訳の 2.7%スペイン: 引用元論文 709 件、この内訳の 2.5%オランダ: 引用元論文 653 件、この内訳の 2.3%韓国: 引用元論文 603 件、この内訳の 2.1%
0%25.7%その他 24%

分野

  • Medicine53.3%
  • Biochemistry, Genetics and Molecular Biology30.7%
  • Immunology and Microbiology6.9%
  • Computer Science5.6%
  • Engineering1%
  • Neuroscience0.8%
  • その他1.7%

トピック

  • Cancer Immunotherapy and Biomarkers9.6%
  • Immunotherapy and Immune Responses3.9%
  • AI in cancer detection2.5%
  • Breast Cancer Treatment Studies2.4%
  • Radiomics and Machine Learning in Medical Imaging2.3%
  • Cancer Cells and Metastasis2.3%
  • その他77%

共著者

全論文

検索で開く
  1. PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    著者: , , , , , , , , , - Nature Reviews Clinical Oncology 2021 被引用: 1,560

  2. Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology

    著者: , , , , - Nature Reviews Clinical Oncology 2019 被引用: 1,579

  3. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen Willard‐Gallo, Sherene Loi - Annals of Oncology 2014 被引用: 3,136

  4. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 1,497

  5. X-Tile

    著者: , , - Clinical Cancer Research 2004 被引用: 3,946

  6. Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2017 被引用: 755

  7. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2020 被引用: 733

  8. Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy

    著者: , , , , , , , , , , , , , , , , , , - Nature Medicine 2019 被引用: 697

  9. Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue

    著者: , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2022 被引用: 346

  10. Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade

    著者: , , , , , , , , , , , , , - JAMA Oncology 2019 被引用: 622

  11. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 799

  12. STING enhances cell death through regulation of reactive oxygen species and DNA damage

    著者: , , , , , , , , , , , , - Nature Communications 2021 被引用: 207

  13. Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer

    著者: , , , , , , - Modern Pathology 2021 被引用: 163

  14. Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes

    著者: , , , , , , , , - Clinical Cancer Research 2019 被引用: 718

  15. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard‐Gallo, An Coosemans, Edith Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M.S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, W. Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernán Garcı́a Rivello, Hugo M. Horlings, Saïd Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group, Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Veronica Bautista ほか 454 名 - npj Breast Cancer 2021 被引用: 275

  16. PD-L1 Expression in Lung Cancer

    著者: , , , , - Journal of Thoracic Oncology 2016 被引用: 492

  17. Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy

    著者: , , , , , , , - Clinical Cancer Research 2019 被引用: 337

  18. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 720

  19. An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy

    著者: , , , , , , , , , - Modern Pathology 2021 被引用: 146

  20. Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 330

  21. Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Evan J. Lipson, Ludmila Danilova, Robert A. Anders, David L. Rimm, Drew M. Pardoll, Alexander S. Szalay, Janis M. Taube - Science 2021 被引用: 204

  22. Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 183

  23. Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 被引用: 108

  24. Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

    著者: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2020 被引用: 369